Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Multiple Sclerosis

  Free Subscription


28.01.2019

4 Ann Neurol
1 Brain
1 Eur Neurol
1 Funct Neurol
1 J Neurol
2 Lancet Neurol
4 Mult Scler
1 PLoS Genet
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Neurol

  1. AZEVEDO CJ, Cen SY, Khadka S, Liu S, et al
    Thalamic Atrophy in MS: An MRI Marker of Neurodegeneration Throughout Disease.
    Ann Neurol. 2018 Jan 12. doi: 10.1002/ana.25150.
    PubMed     Text format     Abstract available

  2. BECK ES, Reich DS
    Brain atrophy in multiple sclerosis: How deep must we go?
    Ann Neurol. 2018;83:208-209.
    PubMed     Text format    

  3. MAGGI P, Absinta M, Grammatico M, Vuolo L, et al
    Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies.
    Ann Neurol. 2018;83:283-294.
    PubMed     Text format     Abstract available

  4. GILES DA, Washnock-Schmid JM, Duncker PC, Dahlawi S, et al
    Myeloid cell plasticity in the evolution of central nervous system autoimmunity.
    Ann Neurol. 2017 Dec 28. doi: 10.1002/ana.25128.
    PubMed     Text format     Abstract available


    Brain

  5. CHEN Y, Podojil JR, Kunjamma RB, Jones J, et al
    Sephin1, which prolongs the integrated stress response, is a promising therapeutic for multiple sclerosis.
    Brain. 2019 Jan 17. pii: 5289373. doi: 10.1093.
    PubMed     Text format     Abstract available


    Eur Neurol

  6. CZARNOWSKA A, Kapica-Topczewska K, Zajkowska O, Swierzbinska R, et al
    Herpesviridae Seropositivity in Patients with Multiple Sclerosis: First Polish Study.
    Eur Neurol. 2019;80.
    PubMed     Text format     Abstract available


    Funct Neurol

  7. PORTARO S, Naro A, Russo M, Bramanti P, et al
    Multiple sclerosis and non-dystrophic myotonias: do they share a common pathophysiology?
    Funct Neurol. 2018;33:194-199.
    PubMed     Text format     Abstract available


    J Neurol

  8. ALCALA C, Gascon F, Perez-Miralles F, Dominguez JA, et al
    Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing-remitting multiple sclerosis is effective and safe.
    J Neurol. 2019 Jan 19. pii: 10.1007/s00415-019-09195.
    PubMed     Text format     Abstract available


    Lancet Neurol

  9. FILIPPI M, Bruck W, Chard D, Fazekas F, et al
    Association between pathological and MRI findings in multiple sclerosis.
    Lancet Neurol. 2019;18:198-210.
    PubMed     Text format     Abstract available

  10. CICCARELLI O, Cohen JA, Reingold SC, Weinshenker BG, et al
    Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders.
    Lancet Neurol. 2019;18:185-197.
    PubMed     Text format     Abstract available


    Mult Scler

  11. STORK L, Bruck W, von Gottberg P, Pulkowski U, et al
    Severe meningo-/encephalitis after daclizumab therapy for multiple sclerosis.
    Mult Scler. 2019 Jan 18:1352458518819098. doi: 10.1177/1352458518819098.
    PubMed     Text format     Abstract available

  12. CORDANI C, Meani A, Esposito F, Valsasina P, et al
    Imaging correlates of hand motor performance in multiple sclerosis: A multiparametric structural and functional MRI study.
    Mult Scler. 2019 Jan 18:1352458518822145. doi: 10.1177/1352458518822145.
    PubMed     Text format     Abstract available

  13. VALENCIA-SANCHEZ C, Goodman BP, Carter JL, Wingerchuk DM, et al
    The spectrum of acute cardiopulmonary events associated with multiple sclerosis exacerbations.
    Mult Scler. 2019 Jan 18:1352458518823482. doi: 10.1177/1352458518823482.
    PubMed     Text format     Abstract available

  14. VAN MUNSTER CE, Kaya L, Obura M, Kalkers NF, et al
    Minimal clinically important difference of improvement on the Arm Function in Multiple Sclerosis Questionnaire (AMSQ).
    Mult Scler. 2019 Jan 18:1352458518823489. doi: 10.1177/1352458518823489.
    PubMed     Text format     Abstract available


    PLoS Genet

  15. CHI C, Shao X, Rhead B, Gonzales E, et al
    Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry.
    PLoS Genet. 2019;15:e1007808.
    PubMed     Text format     Abstract available


    PLoS One

  16. FRAHM N, Hecker M, Zettl UK
    Polypharmacy in outpatients with relapsing-remitting multiple sclerosis: A single-center study.
    PLoS One. 2019;14:e0211120.
    PubMed     Text format     Abstract available

  17. KOBELT G, Teich V, Cavalcanti M, Canzonieri AM, et al
    Burden and cost of multiple sclerosis in Brazil.
    PLoS One. 2019;14:e0208837.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: